IKCS 2020: Non-Clear Cell RCC Session

IKCS 2020: Non-Clear Cell RCC Session

IKCS 2020: Session 5: Multimodality Therapy For Metastatic RCCПодробнее

IKCS 2020: Session 5: Multimodality Therapy For Metastatic RCC

IKCS 2020 Session 4: Metabolism as a Target for RCCПодробнее

IKCS 2020 Session 4: Metabolism as a Target for RCC

Management of Multifocal Non-Clear Cell RCCПодробнее

Management of Multifocal Non-Clear Cell RCC

Dr. Shuch on Biology of Non-Clear Cell RCCПодробнее

Dr. Shuch on Biology of Non-Clear Cell RCC

IKCS 2020: Phase 2 trial of lenvatinib at 2 starting doses+ everolimus in renal cell carcinoma (RCC)Подробнее

IKCS 2020: Phase 2 trial of lenvatinib at 2 starting doses+ everolimus in renal cell carcinoma (RCC)

Non Clear-Cell Type RCCПодробнее

Non Clear-Cell Type RCC

IKCS 2020: Session 1: Multimodality Therapy For Locally Advanced RCCПодробнее

IKCS 2020: Session 1: Multimodality Therapy For Locally Advanced RCC

IKCS 2020: Session 3 Immunotherapy and Emerging Therapies for RCCПодробнее

IKCS 2020: Session 3 Immunotherapy and Emerging Therapies for RCC

KCRS21: Non Clear Cell RCCПодробнее

KCRS21: Non Clear Cell RCC

Promising TKI-ICI combinations for non-clear cell RCCПодробнее

Promising TKI-ICI combinations for non-clear cell RCC

First-line ICIs in advanced non-clear cell RCCПодробнее

First-line ICIs in advanced non-clear cell RCC

Combining lenvatinib & pembrolizumab for non-clear cell RCC: KEYNOTE-B61 study rationaleПодробнее

Combining lenvatinib & pembrolizumab for non-clear cell RCC: KEYNOTE-B61 study rationale

RCC MasterClass and Clinical Consult: Novel Immune and Targeted TherapiesПодробнее

RCC MasterClass and Clinical Consult: Novel Immune and Targeted Therapies

Treating non-clear cell renal cell carcinoma patientsПодробнее

Treating non-clear cell renal cell carcinoma patients

Dr. Srinivasan on Targeted Therapies for Non-Clear Cell RCCПодробнее

Dr. Srinivasan on Targeted Therapies for Non-Clear Cell RCC

IKCS 2020: Metabolic gene signature as biomarker for recurrence in localized clear cell RCCПодробнее

IKCS 2020: Metabolic gene signature as biomarker for recurrence in localized clear cell RCC

Using Combination Therapy as Treatment of Non-Clear Cell RCCПодробнее

Using Combination Therapy as Treatment of Non-Clear Cell RCC

Review of the Data of Frontline Treatment for Non-Clear Cell Kidney CancerПодробнее

Review of the Data of Frontline Treatment for Non-Clear Cell Kidney Cancer